[Re-administration of drotrecogin alfa activated in a patient with episodes of severe sepsis]

Rev Esp Anestesiol Reanim. 2007 Dec;54(10):637-8.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Combined Modality Therapy
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use
  • Fluid Therapy
  • Gastritis / etiology
  • Humans
  • Intestinal Perforation / complications
  • Intestinal Perforation / surgery
  • Middle Aged
  • Multiple Organ Failure / etiology
  • Peritonitis / drug therapy
  • Peritonitis / etiology
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • Postoperative Hemorrhage / chemically induced*
  • Protein C / administration & dosage*
  • Protein C / adverse effects
  • Protein C / therapeutic use
  • Pseudomonas Infections / drug therapy*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / therapeutic use
  • Recurrence
  • Respiration, Artificial
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy
  • Shock, Septic / complications
  • Shock, Septic / drug therapy*
  • Surgical Wound Dehiscence
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Adrenal Cortex Hormones
  • Fibrinolytic Agents
  • Protein C
  • Recombinant Proteins
  • Vasoconstrictor Agents
  • drotrecogin alfa activated